Revert Project

🚀 Unveiling #REVERT’s key achievements: the final project brochure 📘✨ 🎗️ We are thrilled to present the Revert Project's final #brochure, a culmination of groundbreaking research in #personalisedmedicine and #AI-driven solutions in #mCRC. Released during our final event in Rome on December 10th, 2024, this brochure offers an engaging overview of REVERT’s journey and achievements🤝 📄 What’s Inside? 🌟 Discover the cutting-edge AI #algorithms designed to predict treatment outcomes for patients with #metastatic #colorectal #cancer (mCRC). Special attention is given to explainable AI, ensuring trust and usability for clinicians 🌟 Learn how REVERT’s AI-based decision support system (DSS) was validated in a #clinicaltrial across #oncology centers in #Europe, demonstrating real-world benefits in treatment selection 🌟 Explore the creation of the REVERT database, harmonizing clinical, biobank, and real-world data to enhance predictive analytics and support personalized treatment planning 🌟 Dive into innovative organoid-based in vitro studies that refined predictive models and set the stage for novel therapeutic combinations in #cancer care 💡 This brochure reflects the REVERT team’s commitment to advancing personalized medicine and AI-powered #healthcare. It’s a testament to the potential of collaboration and cutting-edge technology in transforming #patientcare 🌐 Download the brochure and join us in celebrating this milestone in oncology innovation! 🙌 Per info ⬇️ https://lnkd.in/dwAZfyMN European Commission European Health and Digital Executive Agency (HaDEA) San Raffaele FONDAZIONE PTV POLICLINICO TOR VERGATA Instituto Murciano de Investigación Biosanitaria (IMIB) Fundación para la Formación e Investigación Sanitarias de la Región de Murcia UCAM Universidad Católica San Antonio de Murcia Malmö stad IMAGO-MOL Cluster Cluster Imago•Mol TRANSCEND - Regional Institute of Oncology Iasi Iași BioVariance GmbH ProMIS - Programma Mattone Internazionale Salute Bundesanstalt für Materialforschung und -prüfung IBBL (Integrated BioBank of Luxembourg) GenXPro GmbH Olomedia #REVERTProject #Cancer #ArtificialIntelligence #PersonalizedTherapies #Horizon2020 #Health #mCRC #CancerResearch

🏆#Rome hosted yesterday December 10th an extraordinary event organised by the Revert Project focusing on #personalizedmedicine and the crucial role of #Artificial Intelligence (#AI) in optimizing #oncologicaltherapies. 🇪🇺 The #REVERT final event gathered experts, patients, institutional representatives, and international stakeholders, marking a pivotal moment for the future of #healthcare in the #EuropeanUnion The final conference featured a range of multidisciplinary sessions: 👉 Plenary sessions: Keynote speeches by renowned experts on cancer & #colorectalcancer medicine. 👉 Roundtables: Discussions on the ethical, economic, regulatory and social implications of emerging #health technologies. 👉 Interactive workshops: Presentations of REVERT project outcomes and patient associations perspectives Through the use of AI, the REVERT project has already achieved tangible results: 🚀 Explainable AI to gaining the #trust of #clinicians in the use of AI #algorithms for a #personalisedtherapeutic intervention 🚀 Innovative AI-based decision support system using a network of biobanks and the experience and the real-world data of several general Hospitals operating in the EU healthcare system 🚀 AI-based multi-party Decision Support System Model led to a significant improvement of #mCRC patients survival The event underscored the importance of ongoing collaboration among #research, #clinicalpractice, #institutions & #patients association, emphasizing the urgency of inclusive and technologically advanced #healthcare #policies. European Commission European Health and Digital Executive Agency (HaDEA) San Raffaele Fondazione PTV Policlinico Tor Vergata Instituto Murciano de Investigación Biosanitaria (IMIB) Fundación para la Formación e Investigación Sanitarias de la Región de Murcia UCAM Universidad Católica San Antonio de Murcia Malmö stad IMAGO-MOL Cluster IMAGO-MOL Cluster TRANSCEND - Regional Institute of Oncology Iasi BioVariance GmbH ProMIS - Programma Mattone Internazionale Salute Bundesanstalt für Materialforschung und -prüfung IBBL (Integrated BioBank of Luxembourg) GenXPro GmbH Olomedia #REVERTProject #Cancer #ArtificialIntelligence #PersonalizedTherapies #Horizon2020 #Health #mCRC #CancerResearch

📢 Don't miss your chance to join the REVERT Final Event! 📅 When: December 10th, 2024 📍 Where: Spazio Europa, Via IV Novembre 149, #Rome 🇮🇹 (and online 💻) 🧬 Why attend? 🌟 Discover how #AI in #genomics is shaping the future of #personalisedtherapies for #colorectalcancer. 🤝 Connect with #EU policymakers, #healthcare professionals, #patient advocates, and industry leaders. 📈 Engage in insightful discussions about innovation, clinical impacts, and sustainable healthcare solutions. 👉 Secure your spot now: https://lnkd.in/dFgd5kDp #REVERTProject #Cancer #ArtificialIntelligence #PersonalizedTherapies #Horizon2020 #Health #mCRC #CancerResearch

🎉 We are thrilled to share that Professor Fiorella Guadagni, Coordinator of the Revert Project, has been honored with the prestigious “Chimera d’Oro” Award 🏆 on November 18 in Arezzo for her outstanding contributions to #medicine and #scientificresearch 🔬 A true pioneer in precision medicine, Professor Guadagni’s groundbreaking work in diagnostic methodologies and anti-cancer treatments has been instrumental in advancing healthcare worldwide. Her leadership in the REVERT project and her achievements at the IRCCS San Raffaele Institute further e. Her remarkable legacy has been a driving force behind the success of the #REVERT project, where her visionary leadership and expertise have guided groundbreaking advancements in personalized #cancer treatments. By harnessing #artificialintelligence and biomarker discoveries, Professor Guadagni has paved the way for innovative approaches that are transforming therapeutic outcomes and shaping the future of precision #medicine. ℹ️ https://lnkd.in/eNmxmHTv

📢 REGISTER & PARTICIPATE IN THE REVERT FINAL EVENT! 🌟 🌐 On December 10th, 2024, we’ll gather at Spazio Europa in #Rome (and online!) to celebrate the groundbreaking results of the Revert Project. 🧬 Discover how #AI in #genomics is revolutionising #personalisedtherapies for #colorectalcancer 🤝 Meet and collaborate with #EU policymakers, #healthcare providers, #patient associations, and industry experts. 📈 Dive into discussions on the future of cancer treatment, focusing on regulatory developments, clinical impacts, and sustainable pathways for integrating innovation into healthcare. Key details: 📅 Date: December 10th, 2024 📍 Location: Spazio Europa, Via IV Novembre 149, #Rome, Italy 🇮🇹 💻 Hybrid event: Participate online if you can’t join in person! 🔗 Register by December 5th: Click here to secure your spot: https://lnkd.in/dFgd5kDp ✨ Don’t miss this opportunity to network, exchange ideas, and contribute to the future of personalized cancer therapies. ➡➡Follow the REVERT LinkedIn page for updates and the full agenda ⬅⬅ ℹ Other info ⬇ https://lnkd.in/d3ZgRSn6 European Health and Digital Executive Agency (HaDEA) San Raffaele FONDAZIONE PTV POLICLINICO TOR VERGATA Instituto Murciano de Investigación Biosanitaria (IMIB) Fundación para la Formación e Investigación Sanitarias de la Región de Murcia UCAM Universidad Católica San Antonio de Murcia Malmö stad IMAGO-MOL Cluster Cluster Imago•Mol TRANSCEND - Regional Institute of Oncology Iasi Iași BioVariance GmbH ProMIS - Programma Mattone Internazionale Salute Bundesanstalt für Materialforschung und -prüfung IBBL (Integrated BioBank of Luxembourg) GenXPro GmbH #REVERTProject #Cancer #ArtificialIntelligence #PersonalizedTherapies #Horizon2020 #Health #mCRC #CancerResearch

SAVE THE DATE 🏁 REVERT FINAL EVENT 🏁 📍 Where: Rome, Spazio Europa - Via Quattro Novembre, 149 📆 When: December 10, 2024 Join us at the Revert Project’s Final Conference! 🌍🔬 Dive into cutting-edge advances in #personalizedtherapies for #colorectalcancer, focusing on #AI applications in #genomics. Connect with EU policymakers, #healthcare providers, patient associations, and industry experts at an event marking a significant milestone in cancer treatment! 🧬🤝 Don’t miss this unique opportunity to network, share ideas, and contribute to the future of personalized therapies in Europe. Mark your calendar! ✨ ℹ https://lnkd.in/gCP_W94q European Health and Digital Executive Agency (HaDEA) San Raffaele FONDAZIONE PTV POLICLINICO TOR VERGATA Instituto Murciano de Investigación Biosanitaria (IMIB) Fundación para la Formación e Investigación Sanitarias de la Región de Murcia UCAM Universidad Católica San Antonio de Murcia Malmö stad IMAGO-MOL Cluster Cluster Imago•Mol TRANSCEND - Regional Institute of Oncology Iasi BioVariance GmbH ProMIS - Programma Mattone Internazionale Salute Bundesanstalt für Materialforschung und -prüfung IBBL (Integrated BioBank of Luxembourg) GenXPro GmbH #REVERTProject #Cancer #ArtificialIntelligence #PersonalizedTherapies ##Horizon2020 #Health #mCRC #CancerResearch

🌟 Revert Project takes center stage at the 2nd Global Summit on #ArtificialIntelligence (GSAI) 🌍 On August 21, 2024, Professor Fiorella Guadagni, a renowned expert in Clinical Biochemistry and Molecular Biology from San Raffaele Roma Open University and coordinator of the #REVERT project, participated in the Global Summit on Artificial Intelligence 🌐 organised by Heighten Science Publications Prof. Guadagni delivered a compelling presentation titled: “#Clinician’s Trust in Advanced #AI Systems for Treatment Selection – The REVERT EU Project as a Paradigmatic Example.” She highlighted the transformative potential of Artificial Intelligence (#AI) and #MachineLearning (ML) in #healthcare 🏥, particularly in building clinicians’ trust in AI-based treatment selection systems. By showcasing the REVERT EU project as a case study, she illustrated how this initiative is pioneering new approaches to fostering confidence among medical professionals 🤝 through transparency and shared decision-making in AI-driven models. 🔍 The REVERT EU project’s innovative methodology leverages consensus among multiple AI algorithms to ensure that treatment recommendations are robust and reliable, thereby increasing clinician trust. As Professor Guadagni emphasized: 🗣️ "The key to widespread AI adoption in healthcare lies in creating systems where clinicians remain central to the decision-making process, while AI tools serve as supportive allies rather than opaque arbiters." #ColorectalCancer #HealthcareInnovation #coloncancer #mCRC #coloncancer #mCRC #Horizon2020🌐🔍 👉 For more information ⬇ https://lnkd.in/d3sKGkSw European Health and Digital Executive Agency (HaDEA) San Raffaele FONDAZIONE PTV POLICLINICO TOR VERGATA Instituto Murciano de Investigación Biosanitaria (IMIB) Fundación para la Formación e Investigación Sanitarias de la Región de Murcia UCAM Universidad Católica San Antonio de Murcia Malmö stad BioVariance GmbH ProMIS - Programma Mattone Internazionale Salute Bundesanstalt für Materialforschung und -prüfung IBBL (Integrated BioBank of Luxembourg) GenXPro GmbH Imago-Mol Cluster TRANSCEND - Regional Institute of Oncology Iasi

👥 A Fruitful Gathering to Finalize the Revert Project! 🤝 On July 24-25, the partners of the #REVERT project are meeting in Iasi, Romania 🇷🇴, for an important consortium meeting to optimally finalize the project, which will conclude in December 2024 with the organization of the final conference in #Brussels🎯   📅 On July 24 #REVERT partners met in the morning at the University House / Casa Universitarilor Universitatea „Alexandru Ioan Cuza” din Iași, where they had vibrant discussions on several key topics. They explored the preliminary results and debated on how to implement next steps, in particular on how to exploit the important project results. After a productive morning, partners explored the cultural richness of Iasi🏛️   📅 On July 25 the meeting concluded with a scientific tour showcasing some of Iasi's cutting-edge research facilities. 💱 These two days are not just about meetings but also about fostering collaboration, sharing knowledge, and driving innovation forward. The REVERT project is making significant strides in revolutionizing the treatment of advanced #colorectalcancer, and the collective efforts are paving the way for a brighter future in healthcare. 🌍🔬 🙏 Thanks to Imago-Mol Cluster and TRANSCEND - Regional Institute of Oncology Iasi for the organisation of the fruitful meeting! #REVERTProject #Innovation #Healthcare  #ColorectalCancer #Horizon2020 #CancerResearch #Health #mCRC #coloncancer #AI #ArtificialIntelligence 👩🔬🔬 European Health and Digital Executive Agency (HaDEA) San Raffaele FONDAZIONE PTV POLICLINICO TOR VERGATA Instituto Murciano de Investigación Biosanitaria (IMIB) Fundación para la Formación e Investigación Sanitarias de la Región de Murcia UCAM Universidad Católica San Antonio de Murcia Malmö stad BioVariance GmbH ProMIS - Programma Mattone Internazionale Salute Bundesanstalt für Materialforschung und -prüfung IBBL (Integrated BioBank of Luxembourg) GenXPro GmbH

📣📣📣 Exciting News! for the Revert Project 📣📣📣 🌟 #REVERT's groundbreaking AI-based oncology decision support system has been featured in Open Access Government! 📰✨ 👏 This recognition highlights the innovative work our consortium is doing to revolutionize treatment selection for #patients with unresectable metastatic #colorectal #cancer (#mCRC) through advanced #AI-based decision support systems (DSS) and driven technologies 🤖 🌐 The REVERT project brings together a dynamic consortium of 22 top-tier research #centers, #biobanks, #clinicalfacilities, and four #SMEs from five European countries 🇪🇺, all collaborating to create a multi-party AI-based system that generates a ranked list of treatment options for clinicians to consider. ☣ What makes the #REVERT DSS truly unique is its ability to generate a ranked list of treatment options for clinicians to consider. The system ensures #personalized #treatment #recommendations and promotes explainable AI for greater clinician trust 💡🔬 Read the full article to dive deeper into our journey toward transforming cancer care through AI. The future of #oncology decision support is here 👇 #ArtificialIntelligence #Oncology #Innovation #Healthcare #PersonalizedMedicine https://lnkd.in/dG6bqJwh European Health and Digital Executive Agency (HaDEA) San Raffaele FONDAZIONE PTV POLICLINICO TOR VERGATA Instituto Murciano de Investigación Biosanitaria (IMIB) Fundación para la Formación e Investigación Sanitarias de la Región de Murcia UCAM Universidad Católica San Antonio de Murcia Malmö stad BioVariance GmbH Imago-Mol Cluster TRANSCEND - Regional Institute of Oncology Iasi ProMIS - Programma Mattone Internazionale Salute Bundesanstalt für Materialforschung und -prüfung IBBL (Integrated BioBank of Luxembourg) GenXPro GmbH

The IBBL (Integrated BioBank of Luxembourg) within LIH has teamed up with the Europe-wide Revert Project to redefine colorectal #cancer therapy through the use of AI. 🤖 As part of this the IBBL will use its expertise in quality assurance and standardisation of processing methods to support the decision criteria for the performance of biomarkers associated with colorectal cancer (CRC). 🔎 Learn more: https://lnkd.in/eXe8BcmA